Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Ovarian Neoplasms 3Breast Neoplasms 3Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Platinum-resistant Recurrent Ovarian Cancer 1Multiple Myeloma 1Lymphoma, T-Cell, Peripheral 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Doxorubicin 19Radiotherapy 10Ifosfamide 10apatinib 9anlotinib 8Cyclophosphamide 8camrelizumab 7Vincristine 5Dactinomycin 5toripalimab 3Trabectedin 3Radiation Dose Hypofractionation 3Ipilimumab 3Gemcitabine 3Etoposide 3Docetaxel 3selinexor 2ribociclib 2envafolimab 2brostallicin 2Topotecan 2Thalidomide 2Temozolomide 2Sorafenib 2Oncolytic Virotherapy 2Nivolumab 2Neoadjuvant Therapy 2Melphalan 2Magnetic Resonance Spectroscopy 2Irinotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Sarcoma × 1-dodecylpyridoxal × Clear all
NCT03268772 2020-04-22

PLD and IFO As First-line Treatment for Patients With Advanced or Metastatic STS

Fudan University

Phase 2 Unknown
40 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡